GTF2H5 and ovarian carcinoma: Gayarre J et al. evaluated the prognostic and predictive value of GTF2H5 based on IHC staining in 139 ovarian cancer samples and demonstrated that low GTF2H5 expression is associated with an improved prognosis in ovarian cancer patients, which may be due to cisplatin sensitization (Gayarre et al., 2016).